Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. (SBRA) Market Cap

Sabra Health Care REIT, Inc. has a market capitalization of $5.21B.

Financials based on reported quarter end 2025-12-31

Price: $20.68

0.02 (0.10%)

Market Cap: 5.21B

NASDAQ · time unavailable

CEO: Richard K. Matros

Sector: Real Estate

Industry: REIT - Healthcare Facilities

IPO Date: 2002-04-02

Website: https://www.sabrahealth.com

Sabra Health Care REIT, Inc. (SBRA) - Company Information

Market Cap: 5.21B · Sector: Real Estate

As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.

Analyst Sentiment

65%
Buy

Based on 14 ratings

Analyst 1Y Forecast: $20.89

Average target (based on 3 sources)

Consensus Price Target

Low

$21

Median

$21

High

$22

Average

$21

Potential Upside: 2.5%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 SABRA HEALTH CARE REIT INC (SBRA) — Investment Overview

🧩 Business Model Overview

Sabra Health Care REIT Inc (SBRA) is a self-administered, self-managed real estate investment trust (REIT) focused on the ownership and investment in healthcare-related real estate. SBRA principally invests in properties within the United States and Canada, with a primary emphasis on skilled nursing (SNFs), senior housing (both operating and triple-net), and specialty hospitals. The company’s mission centers on providing stable income and long-term capital appreciation through a diversified portfolio of healthcare assets, managed via a combination of long-term triple-net leases and management contracts. Sabra’s unique approach involves selectively partnering with operators and tenants in the healthcare sector, often focusing on middle-market operators that may be underserved by larger competitors. The company maintains a balanced portfolio of property types and geographies, thus reducing concentration risk and offering resilience to industry cycles. As a REIT, SBRA is structured to distribute the majority of its taxable income as dividends to shareholders, making it an attractive vehicle for income-focused investors.

💰 Revenue Streams & Monetisation Model

The primary revenue stream for Sabra Health Care REIT is rental income derived from its extensive portfolio of healthcare properties. The portfolio is predominantly structured under triple-net lease agreements, whereby the tenant is responsible for property taxes, insurance, and maintenance, significantly limiting landlord operational risk and expense volatility. This structure ensures a steady, predictable revenue flow and aligns the interests of Sabra and its operators. In addition to its net lease assets, SBRA manages a segment of senior housing assets under RIDEA (REIT Investment Diversification and Empowerment Act) structures, where Sabra participates in the underlying operational performance via management contracts with experienced third-party operators. This model enables upside participation in the growth of senior housing operations, albeit with increased operational exposure. Other secondary revenue sources may include interest income from loans receivable, fees from asset management or oversight roles, and gains on disposition of assets when portfolio optimization dictates. The company's focus on high-occupancy, high-quality tenants provides a visibility of cash flows essential for its dividend-paying mandate.

🧠 Competitive Advantages & Market Positioning

Sabra Health Care REIT’s competitive advantages are anchored in its diversified portfolio, conservative capital structure, and strategic relationships within healthcare real estate. Unlike peers with heavier concentration in one property type or operator, Sabra maintains broad diversification across SNFs, senior housing, behavioral health hospitals, and other healthcare facilities, thereby protecting its business from localized downturns or regulatory headwinds in one segment. The company’s disciplined investment underwriting emphasizes operator quality, property fundamentals, and local market dynamics, fostering lower tenant default risk and greater occupancy stability. Management’s track record in proactively managing the portfolio—through asset recycling, selective acquisitions, and prudent balance sheet management—positions Sabra to adapt swiftly to changing industry and macroeconomic conditions. Furthermore, Sabra’s focused partnerships with middle-market operators often provide access to deal flow unattractive or inaccessible to larger REITs, allowing for an attractive risk-adjusted return profile. These relationships underpin a resilient occupancy base and help differentiate the company’s growth path.

🚀 Multi-Year Growth Drivers

Several secular and company-specific factors underpin Sabra’s long-term growth thesis: - **Demographic Tailwinds:** The aging population in North America is fueling demand for skilled nursing, memory care, and senior housing. The demographic cohort aged 80+ is projected to accelerate in growth over the coming decades, driving higher utilization of Sabra’s core asset types. - **Healthcare Expenditure Growth:** Healthcare spending as a percentage of GDP continues to rise, supporting property-level revenues and bolstering tenant credit profiles across the sector. - **Portfolio Optimization:** Sabra pursues an active capital recycling strategy, divesting non-core or underperforming assets and redeploying capital into higher-yield opportunities, thereby enhancing portfolio quality and growth prospects. - **Expansion into Complementary Segments:** The company’s selective moves into behavioral health, rehabilitation hospitals, and medical office facilities open additional avenues for property acquisition and tenant diversification. - **Operational Enhancements in Senior Housing:** Through its RIDEA-managed senior housing assets, Sabra can participate in operating improvements, refurbishments, and repositionings, capturing upside from operational leverage and demographic-driven occupancy gains. - **Industry Consolidation:** Small and mid-sized healthcare operators are increasingly reliant on capital partnerships, offering Sabra a pipeline of acquisition targets or new leases at attractive risk-adjusted yields.

⚠ Risk Factors to Monitor

Investors in Sabra Health Care REIT should remain cognizant of several key risks: - **Tenant Credit Risk:** The financial health of SNF and senior housing operators is central; operational or reimbursement pressure on tenants could lead to rent defaults or renegotiations. - **Regulatory Uncertainty:** Changes in healthcare reimbursement policies, particularly those affecting Medicare and Medicaid, may impact operator profitability and, consequently, Sabra’s rental income. - **Sector-Specific Volatility:** Senior housing and skilled nursing segments can be sensitive to oversupply, labor shortages, and infectious disease outbreaks, all potentially impacting asset cash flows. - **Leverage and Capital Markets Dependence:** Like most REITs, Sabra relies on access to debt and equity markets to fund growth and refinance maturities. Rising interest rates or tighter credit conditions may affect acquisition capacity or dividend safety. - **Operational Exposure in RIDEA Portfolio:** While RIDEA structures offer upside, they also bring greater exposure to the volatility of operational results, which can fluctuate with occupancy trends and expense inflation. - **Concentration Risks:** Although diversified by property type and geography, Sabra may still face regional or operator-specific risks, particularly if large tenants comprise a significant portion of revenues.

📊 Valuation & Market View

In the context of listed healthcare REITs, Sabra Health Care REIT is often valued on a combination of AFFO (Adjusted Funds From Operations) multiples, dividend yield, and NAV (Net Asset Value) per share metrics. Its valuation historically reflects a blend of stable cash flows from triple-net healthcare assets, offset by perceived operational and regulatory risks inherent in its core sectors. Relative to sector peers, Sabra’s diversified asset base and active portfolio management may warrant a modest premium, particularly given its track record of recycling assets and maintaining dividend coverage. Yield-oriented investors are attracted to Sabra’s REIT-compliant dividend distributions, which are backed by contractual revenues from triple-net leases and operating upside potential in managed portfolios. Analyst and market sentiment often weighs macroeconomic considerations such as interest rates, sector rent coverage, and policy developments, balancing the attractiveness of high dividend yields against operational and regulatory headwinds. Sabra’s ability to demonstrate recurring cash flow growth and prudent capital allocation remains an important determinant of its market positioning.

🔍 Investment Takeaway

Sabra Health Care REIT occupies a defensible niche within the healthcare real estate sector, benefiting from demographic mega-trends and a broad, diversified asset base. Its triple-net lease focus provides predictable, inflation-resistant cash flows, while selective exposure to senior housing operations offers participation in the sector’s long-term upside. By partnering with quality middle-market operators and maintaining financial flexibility, Sabra mitigates many of the sector’s headline risks. While investors should be vigilant regarding operator credit quality, regulatory changes, and capital markets accessibility, Sabra’s proactive portfolio management and measured risk-taking support a favorable risk-reward balance. The company’s income-generating profile and strategic positioning within a growing sector make it a compelling candidate for income-oriented and total-return-focused real estate investors, provided risks are diligently monitored and evaluated.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"SBRA reported revenue of $211.9M and a net income of $27.2M, resulting in an EPS of $0.11. Despite significant total assets of $5.49B, the company is facing consistent operational challenges, reflected in a lack of positive operating cash flow or free cash flow. While the dividends paid are consistently $0.30 per share, the absence of cash generated from operations raises concerns about sustainability. The total liabilities are $2.67B, leading to a net debt of $2.48B, which could functionally limit growth opportunities. SBRA has exhibited a 1-year price change of 13.72%, which reflects moderate market performance but does not surpass the 20% threshold for substantial price appreciation. Analyst price targets suggest upside potential, with a consensus price target of $21.33. Overall, SBRA's financial health indicates some profitability and dividend provision, but operational cash flow remains a significant area of concern for investors."

Revenue Growth

Neutral

Moderate revenue of $211.9M with potential for growth.

Profitability

Fair

Positive net income of $27.2M; however, profit margins could improve.

Cash Flow Quality

Neutral

No operating or free cash flow reported, raising concerns about liquidity.

Leverage & Balance Sheet

Caution

High net debt relative to equity may pose risks.

Shareholder Returns

Fair

Consistent dividend payments, but lack of cash flow for sustainability.

Analyst Sentiment & Valuation

Neutral

Price targets indicate some upside, but growth potential is limited.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

SBRA delivered strong Q4 results led by SHOP outperformance, with sequential revenue and NOI gains, rising occupancy, and margin expansion. Management guided to ~5% growth in normalized FFO/AFFO per share for 2026, underpinned by low-to-mid-teens SHOP same-store NOI growth and a robust, largely senior-housing-focused investment pipeline expected to exceed 2025 volume. Balance sheet leverage remains at target with ample liquidity and no near-term debt maturities. While competition for deals and inflation remain considerations and some transition assets lag, the tone and outlook are positive, supported by stable regulation, improving skilled nursing coverage, and clear visibility on funded growth.

Growth

  • SHOP managed portfolio sequential revenue +15.8% and cash NOI +18.4% with 60 bps margin expansion
  • Same-store managed senior housing revenue +6.4% YoY; cash NOI +12.6% YoY
  • Same-store occupancy up 160 bps YoY to 87.9% (U.S. +80 bps to 84.7%; Canada +300 bps to 94.2%)
  • RevPOR +4.2% YoY (Canada +5.2%); expense growth (XPOR) +1.6% YoY
  • Skilled nursing portfolio rent coverage at an all-time high and occupancy up
  • 2026 guidance: normalized FFO/AFFO per share midpoint ~+5% vs 2025; SHOP same-store cash NOI growth low to mid-teens; triple-net cash NOI low single-digit

Business Development

  • Approx. $450M of 2025 investments at ~7.5% initial cash yield; average asset age <10 years
  • Q4 added four managed senior housing properties (> $150M); $27M additional managed assets closed post year-end
  • Awarded pipeline: ~$240M expected to close mostly in Q1–early Q2 2026 (includes ~$220M senior housing and ~$20M skilled nursing)
  • Expect 2026 investment volume to materially exceed 2025; no awarded deals fell out

Financials

  • Q4 2025 normalized FFO/share $0.36; normalized AFFO/share $0.38
  • Q4 normalized FFO $91.2M; normalized AFFO $95.2M
  • Managed SH cash NOI $35.6M (up $5.5M QoQ); triple-net cash NOI down $1.3M QoQ due to prior lease-to-SHOP transitions; net cash NOI +$4.2M QoQ
  • Interest and other income $10.6M vs $12.7M in Q3 (prior lease termination income timing)
  • Cash interest expense $26.6M (flat QoQ); cash G&A $12.5M (includes performance comp true-up); underlying cash G&A ~$10.6M
  • 2026 guidance: net income $0.60–$0.64; FFO (normalized) $1.49–$1.53; AFFO (normalized) $1.55–$1.59
  • 2026 assumptions: G&A ~$52M (incl. $12M SBC); cash interest ~$103M; WASC ~255–256M; no unannounced dispositions or capital markets actions

Capital & Funding

  • Net debt to adjusted EBITDA 5.00x at 12/31/25 (down 0.27x YoY), in line with target
  • Weighted average debt cost 3.92%; WA remaining term 4.2 years; next material maturity 2028
  • No floating-rate exposure in permanent debt; only revolver is floating
  • ATM forward equity: $206M issued in Q4 at $18.79/share; $322.7M total forwards outstanding at $18.60/share; $40M settled in Q4
  • Liquidity ~$1.2B (cash $71.5M; revolver availability $782.4M; forwards $322.7M); $483M remaining ATM capacity
  • Quarterly dividend $0.30/share (declared 02/02/26), ~79% of Q4 normalized AFFO/share; management states dividend is adequately covered

Operations & Strategy

  • Focus on SHOP platform; majority of new investments expected in managed senior housing (~95% of opportunities)
  • Four senior housing assets transitioned from triple-net to SHOP in 2025 to drive operating upside
  • SHOP occupancy just under 88% in Q4; management targets low-90s in 2026; mid-90s viewed as effectively full
  • Holiday transition assets currently lag portfolio but have longer runway; expected to bolster 2026 SHOP growth
  • Maintenance CapEx expected similar to recent run-rate; nonrecurring SHOP CapEx estimated at $20–$30M in 2026
  • Top 10 triple-net relationships performing well; regulatory environment stable

Market & Outlook

  • Industry tailwinds supporting senior housing demand; Canadian portfolio occupancy >90% for seven consecutive quarters
  • Robust deal flow despite rising investor interest; management expects to exceed 2025 investment volume in 2026
  • 2026 SHOP same-store growth driven by occupancy gains, modest rate growth, and expense growth in line with inflation
  • Guidance assumes no changes in tenant revenue recognition status and no unannounced capital markets/dispositions

Risks Or Headwinds

  • Increased competition for senior housing deals may pressure yields
  • Expense inflation could pressure margins if above expectations
  • Guidance sensitive to tenant revenue recognition status (assumes no changes)
  • Holiday/transition assets currently underperforming portfolio averages
  • Loans receivable: RCA loan maturity discussions ongoing; guidance assumes status quo
  • Equity issuance via ATM forwards implies potential dilution, though used to fund growth leverage-neutrally

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the SBRA Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (SBRA)

© 2026 Stock Market Info — Sabra Health Care REIT, Inc. (SBRA) Financial Profile